DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-1.67%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.11B
AUM Growth
+$5.11B
(-9.2%)
Cap. Flow
+$49.9M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
36.57%
Holding
172
New
27
Increased
20
Reduced
18
Closed
38
Top Buys
| 1 |
Nuvalent
NUVL
|
$436M |
| 2 |
GeneDx Holdings
WGS
|
$105M |
| 3 |
Neurocrine Biosciences
NBIX
|
$40M |
| 4 |
Glaukos
GKOS
|
$29.8M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$24.5M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$54.4M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$54.1M |
| 3 |
QuidelOrtho
QDEL
|
$52.4M |
| 4 |
Galapagos
GLPG
|
$45.3M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$42.5M |
Sector Composition
| 1 | Healthcare | 66.55% |
| 2 | Financials | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
KalVista Pharmaceuticals
KALV
$713M
| $37.8M | 0.74% |
2,163,554
| – | – |
|
27
Nuvation Bio
NUVB
$1.08B
| $35.6M | 0.69% |
3,577,233
| – | – |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $33.9M | 0.66% |
2,977,020
+2,151,083
| +260% | +$24.5M |
|
|
BDSI
29
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $33.1M | 0.65% |
9,170,699
-359,301
| -4% | -$1.3M |
|
30
Brookdale Senior Living
BKD
$1.81B
| $33.1M | 0.65% |
5,252,800
+1,954,800
| +59% | +$12.3M |
|
|
SWTX
31
DELISTED
SpringWorks Therapeutics
SWTX
| $32.4M | 0.63% |
510,673
-47,901
| -9% | -$3.04M |
|
32
Werewolf Therapeutics
HOWL
$62.6M
| $30.1M | 0.59% |
1,752,787
-800,000
| -31% | -$13.7M |
|
|
33
Glaukos
GKOS
$5.42B
| $29.8M | 0.58% |
+619,000
| New | +$29.8M |
|
|
ONCR
34
DELISTED
Oncorus, Inc.
ONCR
| $29.4M | 0.57% |
3,148,977
| – | – |
|
35
Pharvaris
PHVS
$1.41B
| $28.5M | 0.56% |
1,608,471
+575,714
| +56% | +$10.2M |
|
|
DCPH
36
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $27.7M | 0.54% |
815,000
-528,560
| -39% | -$18M |
|
|
INZY
37
DELISTED
Inozyme Pharma
INZY
| $27.2M | 0.53% |
2,344,786
+165,801
| +8% | +$1.92M |
|
38
Rhythm Pharmaceuticals
RYTM
$6.75B
| $26M | 0.51% |
1,989,625
| – | – |
|
|
XLRN
39
DELISTED
Acceleron Pharma Inc.
XLRN
| $25M | 0.49% |
145,000
-74,500
| -34% | -$12.8M |
|
40
Protagonist Therapeutics
PTGX
$3.62B
| $24.7M | 0.48% |
1,394,000
+31,210
| +2% | +$553K |
|
41
Terns Pharmaceuticals
TERN
$651M
| $24.4M | 0.48% |
2,345,959
| – | – |
|
42
Alector
ALEC
$282M
| $24.1M | 0.47% |
1,055,192
| – | – |
|
43
PMV Pharmaceuticals
PMVP
$82.1M
| $24M | 0.47% |
804,000
| – | – |
|
|
KNTE
44
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $23.7M | 0.46% |
1,028,508
+8,508
| +0.8% | +$196K |
|
45
Cullinan Oncology
CGEM
$456M
| $23.6M | 0.46% |
1,044,000
| – | – |
|
|
AFIB
46
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $23.4M | 0.46% |
2,648,386
-1,693,413
| -39% | -$15M |
|
|
VINC
47
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $22.3M | 0.44% |
+1,379,310
| New | +$22.3M |
|
48
Fate Therapeutics
FATE
$115M
| $21.5M | 0.42% |
362,000
+58,000
| +19% | +$3.44M |
|
|
ITMR
49
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $21M | 0.41% |
694,667
-499,136
| -42% | -$15.1M |
|
50
Instil Bio
TIL
$196M
| $19.9M | 0.39% |
1,115,739
| – | – |
|